A carregar...
Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis
The off-label use of bevacizumab labeled with 99mTc as a new radiopharmaceutical for imaging of endometriosis is a promising noninvasive, new clinical procedure. The bevacizumab in monoclonal antibodies targeted at vascular endothelial growth factor (VEGF) is superexpressed in cases of endometriosis...
Na minha lista:
| Publicado no: | Biomed Res Int |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4512512/ https://ncbi.nlm.nih.gov/pubmed/26240826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/751460 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|